Swedish biopharmaceutical company Orphan Biovitrum AB (Sobi) has signed an agreement to acquire American Arthrosi Therapeutics for $1.5 billion. This is reported in a press release from Viva Biotech.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results